Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Kevin J. Curran"'
Autor:
Liora M. Schultz, Anne Eaton, Christina Baggott, Jenna Rossoff, Snehit Prabhu, Amy K. Keating, Christa Krupski, Holly Pacenta, Christine L. Philips, Julie-An Talano, Amy Moskop, Susanne H.C. Baumeister, Gary Douglas Myers, Nicole A. Karras, Patrick A. Brown, Muna Qayed, Michelle Hermiston, Prakash Satwani, Rachel Wilcox, Cara A. Rabik, Vanessa A. Fabrizio, Vasant Chinnabhandar, Michael Kunicki, Sharon Mavroukakis, Emily Egeler, Yimei Li, Crystal L. Mackall, Kevin J. Curran, Michael R. Verneris, Theodore W. Laetsch, Heather Stefanski
Publikováno v:
Journal of Clinical Oncology. 41:354-363
PURPOSE Nonresponse and relapse after CD19-chimeric antigen receptor (CAR) T-cell therapy continue to challenge survival outcomes. Phase II landmark data from the ELIANA trial demonstrated nonresponse and relapse rates of 14.5% and 28%, respectively,
Autor:
Audrey Mauguen, Snehit Prabhu, Christine L Phillips, Kevin J. Curran, Michael Kunicki, Prakash Satwani, Theodore W. Laetsch, Rachel Wilcox, Muna Qayed, Vasant Chinnabhandar, Crystal L. Mackall, Steven P. Margossian, Michael R. Verneris, Michelle L. Hermiston, Vanessa A Fabrizio, Christina Baggott, Julie-An An Talano, Emily Egeler, Gary Doug Myers, A. Yasemin Goksenin, Amy Moskop, Cara A Rabik, Holly L Pacenta, Amy K. Keating, Jenna Rossoff, Christa Krupski, Heather E. Stefanski, Patrick A. Brown, Nicole Karras, Jaap Jan Boelens, Sharon Mavroukakis, Liora M. Schultz
Publikováno v:
Blood advances, vol 6, iss 7
Chimeric antigen receptor (CAR) T cells provide a therapeutic option in hematologic malignancies. However, treatment failure after initial response approaches 50%. In allogeneic hematopoietic cell transplantation, optimal fludarabine exposure improve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fab5a5590ca98bdc6c2ccd6b052b9feb
https://escholarship.org/uc/item/6xt142fk
https://escholarship.org/uc/item/6xt142fk
Autor:
Miguel-Angel Perales, Raghav Chawla, Paul L. Martin, Manali Kamdar, Cameron J. Turtle, Joshua P. Sasine, Eric Bleickardt, Kevin J. Curran, Marcelo C. Pasquini, Sarah Nikiforow, Peiman Hematti, Lan Yi, Theodore W. Laetsch, Amy K. Keating, Monalisa Ghosh, Steven P. Margossian, Michael A. Pulsipher, Joseph Rosenthal, Amy Moskop, Dana Salzberg, Matthew J. Frigault, Patricia Steinert, Christine L Phillips, Rayne H. Rouce, Stephan A. Grupp, Daniel J. Landsburg, Mary M. Horowitz, Zhen-Huan Hu, Lida Bubuteishvili Pacaud, Samantha Jaglowski, Frederick L. Locke
Publikováno v:
Blood Advances. 4:5414-5424
Tisagenlecleucel is a CD19 chimeric antigen receptor (CAR) T-cell therapy approved for treatment of pediatric and young adult patients with relapsed/refractory acute lymphoblastic leukemia (ALL) and adults with non-Hodgkin lymphoma (NHL). The initial
Autor:
Andromachi Scaradavou, Richard J. O'Reilly, Jaap Jan Boelens, Farid Boulad, Susan E. Prockop, Barbara Spitzer, Ichelle van Roessel, Andrew L. Kung, Maria Cancio, Kevin J. Curran, Nancy A. Kernan, Elizabeth Klein
Publikováno v:
Cytotherapy
An association between early CD4+ T cell immune reconstitution (CD4+ IR) and survival after T-replete allogeneic hematopoietic cell transplantation (HCT) has been previously reported. Here we report validation of this relationship in a separate cohor
Autor:
Steven P. Margossian, Rachel Wilcox, Michelle L. Hermiston, Holly L Pacenta, Heather E. Stefanski, Christina Baggott, Muna Qayed, Vanessa A Fabrizio, G.D. Myers, Snehit Prabhu, Vasant Chinnabhandar, Kevin J Curran, Michael R. Verneris, A. Yasemin Goksenin, Theodore W. Laetsch, Prakash Satwani, Christine L Phillips, Julie-An Talano, Crystal L. Mackall, Michael Kunicki, Liora M. Schultz, Amy Moskop, Nicole Karras, Patrick A. Brown, Cara A Rabik, Amy K. Keating, Jenna Rossoff, Christa Krupski
Publikováno v:
Blood
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32d233911e1462c7c5bebdda65fda5c0
https://europepmc.org/articles/PMC8617436/
https://europepmc.org/articles/PMC8617436/
Autor:
Andromachi Scaradavou, Richard J. O'Reilly, Maria Cancio, Elizabeth Klein, Barbara Spitzer, Susan E. Prockop, Jaap Jan Boelens, Joannne Torok-Castanza, Audrey Mauguen, Julianne Ruggiero, Nancy A. Kernan, Kevin J. Curran, Farid Boulad, Jennifer Allen
Publikováno v:
Transplantation and Cellular Therapy. 27:S137-S139
Autor:
Neerav Shukla, Kavitha Ramaswamy, Sanam Shahid, Christopher J. Forlenza, Jae H. Park, Nancy A. Kernan, Karlo Perica, Kevin J. Curran, Audrey Mauguen, Jaap Jan Boelens, Peter G. Steinherz, Steven P. Margossian, Jessica Flynn
Publikováno v:
Transplant Cell Ther
Chimeric antigen receptor (CAR) T cells achieve response and durable remission in patients with relapsed/refractory (R/R) B cell malignancies. Following collection of patient T cells, chemotherapy ("bridging chemotherapy") is utilized during the manu
Autor:
Andromachi Scaradavou, Maria Cancio, Celina L. Szanto, Mirjam E. Belderbos, Elizabeth Klein, Wouter J.W. Kollen, Farid Boulad, Nancy A. Kernan, Dorine Bresters, Marc Bierings, Stefan Nierkens, Kevin J. Curran, Barbara Spitzer, Coco de Koning, Jurgen Langenhorst, Jaap Jan Boelens, Birgitta Versluijs, Caroline A. Lindemans, Susan E. Prockop, Alwin D. R. Huitema, Ichelle van Roessel, Richard J. O'Reilly
Publikováno v:
Blood
Acute graft-versus-host-Disease (aGVHD) is a major cause of morbidity and mortality after allogeneic hematopoietic cell transplantation (HCT). We previously showed that early CD4+ T-cell immune reconstitution (IR; CD4+ IR) predicts survival after HCT
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5555c041f4a96722046831f6ef4a6558
https://europepmc.org/articles/PMC7986048/
https://europepmc.org/articles/PMC7986048/
Autor:
Andromachi Scaradavou, Meghan A. Higman, Barbara Spitzer, Jennifer Allen, Nicholas D. Yeager, Audrey Mauguen, Nancy A. Kernan, Elliot Stieglitz, Maria Cancio, Farid Boulad, Niketa C. Shah, Kevin J Curran, Vanessa A Fabrizio, Susan E. Prockop, Steven P. Margossian, Richard J. O'Reilly, Renier J. Brentjens, Jaap Jan Boelens
Publikováno v:
Bone marrow transplantation, vol 55, iss 11
Bone marrow transplantation
Bone marrow transplantation
To define the tolerability and outcome of allogeneic hematopoietic stem cell transplant (allo-HSCT) following CAR T-cell therapy, we retrospectively reviewed pediatric/young adult patients with relapsed/refractory B-ALL who underwent this treatment.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32cde197e69454cd2acee0da2cb995dc
https://escholarship.org/uc/item/9sv0d1wj
https://escholarship.org/uc/item/9sv0d1wj
Autor:
Nicole Karras, Michelle L. Hermiston, Julie-An Talano, Cara A Rabik, Yasemin Goksenin, Heather E. Stefanski, Theodore W. Laetsch, M. Christa Krupski, Liora M. Schultz, Christine L Phillips, Patrick A. Brown, Snehit Prabhu, Muna Qayed, Amy K. Keating, Christina Baggott, Kevin J. Curran, Crystal L. Mackall, Douglas Myers, Amy Moskop, Jenna Rossoff, Vasant Chinnabhandar, Prakash Satwani, Michael R. Verneris, Steven P. Margossian, Rachel Wilcox, Holly L Pacenta, Vanessa A Fabrizio
Publikováno v:
Transplantation and Cellular Therapy. 27:S335-S336